Zydus Lifesciences Secures USFDA Nod for Deflazacort Tablets; Shares Gain
Zydus Lifesciences‘ share price continued its upward momentum for a second straight day, climbing 1% in early trading on 15 April after receiving approval from...
Tag : USFDA approval
Cipla Shares Rallied 5% on Securing Approval from USFDA
The share price of Cipla Ltd rallied 5% on 11 April after the company announced securing approval from the US Food and Drug Administration (USFDA)...
Biocon Subsidiary Secures USFDA Approval
Biocon Biologics, a subsidiary of Biocon, reported on Thursday, 10 April, that the US Food and Drug Administration (FDA) had approved its antibody Jobevne. The...
Biocon Shares Surge 2% on Approval from USFDA for Blood Pressure Drug
Shares of Biocon Ltd were trading in the green and 2% higher on 24 March after the company’s subsidiary announced securing approval from the USFDA...
Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA
Shares of pharmaceutical major Biocon Ltd were trading in the green and 3% higher on 5 March after the company that its wholly-owned subsidiary secured...
Lupin Shares Crash 5% Despite Securing USFDA Approval
Shares of Lupin Ltd crashed 5% on 11 February despite the US Food and Drug Administration’s (USFDA) approval of the company’s nasal spray. The USFDA...
Lupin Shares Gain on Receiving Approval from USFDA
Shares of Lupin Ltd were trading in the green and 1% higher on 19 December after the company announced receiving approval from the US Food...
Gland Pharma Shares Rally 5% on Securing USFDA Approval
Shares of Gland Pharma Ltd rallied 4.99% on 12 December after the company announced securing drug approval from the US Food and Medication Administration (USFDA)....
Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval
Shares of Biocon rallied 4% on Monday, 2 December, after the company announced that its subsidiary, Biocon Biologics, had received approval from the US Food...
Shilpa Medicare-Zydus Lifesciences JV Secures USFDA Approval
Shilpa Medicare, in partnership with the Zydus Group through their joint venture Oncosol, and its collaborator Shorla Oncology, announced on November 27 that the USFDA...
